JWH-122
Overview[edit]
JWH-122 is a synthetic cannabinoid that acts as a potent agonist of the cannabinoid receptors. It is part of the naphthoylindole family of compounds and is used in scientific research to study the endocannabinoid system.
Chemical Structure[edit]
JWH-122 has a chemical structure that includes a naphthoylindole core. The full chemical name is 1-Pentyl-3-(4-methyl-1-naphthoyl)indole. This structure is similar to other synthetic cannabinoids, such as JWH-018 and JWH-073, which also belong to the naphthoylindole class.
Pharmacology[edit]
JWH-122 acts as a full agonist at both the CB1 and CB2 cannabinoid receptors. It has a higher affinity for the CB1 receptor, which is primarily found in the central nervous system. This receptor interaction is responsible for the psychoactive effects associated with cannabinoids.
Effects[edit]
The effects of JWH-122 are similar to those of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. Users may experience altered perception, mood changes, and cognitive effects. However, as a synthetic compound, JWH-122 can have unpredictable and potentially severe side effects.
Legal Status[edit]
Due to its potential for abuse and lack of medical use, JWH-122 is classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and "designer drugs."
Research[edit]
JWH-122 is used in research to better understand the endocannabinoid system and the effects of cannabinoid receptor activation. Studies often focus on its binding affinity, efficacy, and potential therapeutic applications.
